APTEVO THERAPEUTICS INC (APVO) Fundamental Analysis & Valuation

NASDAQ:APVO • US03835L7029

Current stock price

4.42 USD
-0.15 (-3.28%)
At close:
4.31 USD
-0.11 (-2.49%)
After Hours:

This APVO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. APVO Profitability Analysis

1.1 Basic Checks

  • In the past year APVO has reported negative net income.
  • In the past year APVO has reported a negative cash flow from operations.
  • APVO had negative earnings in 4 of the past 5 years.
  • APVO had a negative operating cash flow in each of the past 5 years.
APVO Yearly Net Income VS EBIT VS OCF VS FCFAPVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • APVO's Return On Assets of -103.54% is on the low side compared to the rest of the industry. APVO is outperformed by 76.49% of its industry peers.
  • APVO's Return On Equity of -160.72% is on the low side compared to the rest of the industry. APVO is outperformed by 64.93% of its industry peers.
Industry RankSector Rank
ROA -103.54%
ROE -160.72%
ROIC N/A
ROA(3y)-66.85%
ROA(5y)-56.8%
ROE(3y)-200.85%
ROE(5y)-609.94%
ROIC(3y)N/A
ROIC(5y)N/A
APVO Yearly ROA, ROE, ROICAPVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for APVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APVO Yearly Profit, Operating, Gross MarginsAPVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. APVO Health Analysis

2.1 Basic Checks

  • APVO has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for APVO has been increased compared to 5 years ago.
  • APVO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
APVO Yearly Shares OutstandingAPVO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10K 20K 30K
APVO Yearly Total Debt VS Total AssetsAPVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • APVO has an Altman-Z score of -16.18. This is a bad value and indicates that APVO is not financially healthy and even has some risk of bankruptcy.
  • APVO has a Altman-Z score of -16.18. This is amonst the worse of the industry: APVO underperforms 81.12% of its industry peers.
  • APVO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.18
ROIC/WACCN/A
WACCN/A
APVO Yearly LT Debt VS Equity VS FCFAPVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.03 indicates that APVO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.03, APVO is in line with its industry, outperforming 47.59% of the companies in the same industry.
  • A Quick Ratio of 4.03 indicates that APVO has no problem at all paying its short term obligations.
  • APVO has a Quick ratio (4.03) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
APVO Yearly Current Assets VS Current LiabilitesAPVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. APVO Growth Analysis

3.1 Past

  • APVO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.75%, which is quite impressive.
EPS 1Y (TTM)74.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • APVO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.87% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.07%
EPS Next 2Y41.32%
EPS Next 3Y25.94%
EPS Next 5Y14.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
APVO Yearly Revenue VS EstimatesAPVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2029 2030 2031 2032 50M 100M 150M
APVO Yearly EPS VS EstimatesAPVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1M -2M -3M

More info and screens

Find the best growth stocksShow best growing peers

1

4. APVO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for APVO. In the last year negative earnings were reported.
  • Also next year APVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APVO Price Earnings VS Forward Price EarningsAPVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APVO Per share dataAPVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K

4.3 Compensation for Growth

  • A more expensive valuation may be justified as APVO's earnings are expected to grow with 25.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.32%
EPS Next 3Y25.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. APVO Dividend Analysis

5.1 Amount

  • APVO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

APVO Fundamentals: All Metrics, Ratios and Statistics

APTEVO THERAPEUTICS INC

NASDAQ:APVO (3/13/2026, 8:10:03 PM)

After market: 4.31 -0.11 (-2.49%)

4.42

-0.15 (-3.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-02
Earnings (Next)05-12
Inst Owners2.57%
Inst Owner Change-95.89%
Ins Owners0.08%
Ins Owner Change2.09%
Market Cap4.42M
Revenue(TTM)N/A
Net Income(TTM)-27.95M
Analysts82.86
Price Target7711.2 (174361.54%)
Short Float %13.35%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.43%
Min EPS beat(2)12.75%
Max EPS beat(2)90.1%
EPS beat(4)2
Avg EPS beat(4)-210.34%
Min EPS beat(4)-942%
Max EPS beat(4)90.1%
EPS beat(8)6
Avg EPS beat(8)-73.73%
EPS beat(12)9
Avg EPS beat(12)-32.62%
EPS beat(16)12
Avg EPS beat(16)6.37%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1700%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1700%
EPS NY rev (1m)0%
EPS NY rev (3m)-1700%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA N/A
EPS(TTM)-3412.48
EYN/A
EPS(NY)-29.38
Fwd EYN/A
FCF(TTM)-26.11
FCFYN/A
OCF(TTM)-26.11
OCFYN/A
SpS0
BVpS17.39
TBVpS17.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -103.54%
ROE -160.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-66.85%
ROA(5y)-56.8%
ROE(3y)-200.85%
ROE(5y)-609.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z -16.18
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.57%
EPS Next Y99.07%
EPS Next 2Y41.32%
EPS Next 3Y25.94%
EPS Next 5Y14.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-110.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.33%
OCF growth 3YN/A
OCF growth 5YN/A

APTEVO THERAPEUTICS INC / APVO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of APTEVO THERAPEUTICS INC (APVO) stock?

ChartMill assigns a fundamental rating of 2 / 10 to APVO.


What is the valuation status of APTEVO THERAPEUTICS INC (APVO) stock?

ChartMill assigns a valuation rating of 1 / 10 to APTEVO THERAPEUTICS INC (APVO). This can be considered as Overvalued.


How profitable is APTEVO THERAPEUTICS INC (APVO) stock?

APTEVO THERAPEUTICS INC (APVO) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for APVO stock?

The Earnings per Share (EPS) of APTEVO THERAPEUTICS INC (APVO) is expected to grow by 99.07% in the next year.